Lupin Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500257	NSE Symbol:	LUPIN	P/E :	18.82
ISIN Demat:	INE326A01037	Div & Yield %:	0.53	EPS :	120.95
Book Value:	595.49	Market Cap (Rs. Cr.):	104,090.54	Face Value :	2

Date	Headline
02-Apr-26	Lupin completes acquisition of VISUfarma
30-Mar-26	Nanomi (Lupin arm) hikes stake in its subsidiary Multicare Pharmaceuticals Philippines
25-Mar-26	Lupin receives USFDA tentative approval for Pitolisant Tablets, 4.45mg and 17.8mg
24-Mar-26	Lupin allots 1.35 lakh equity shares under ESOP
19-Mar-26	Lupin announces strategic expansion of CRDMO capabilities at its Dabhasa facility
27-Feb-26	Lupin receives EIR report with VAI classification for its Goa unit
25-Feb-26	Lupin receives USFDA approval for Brivaracetam Oral Solution 10 mg/mL
23-Feb-26	Lupin receives European Commission approval for Biosimilar Ranibizumab
13-Feb-26	Lupin allots 75,273 equity shares under ESOP
10-Feb-26	Lupin settles patent dispute with Astellas

Company Snapshot